A 5-year (1990–1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations
- 1 September 1996
- journal article
- Published by Elsevier in Early Human Development
- Vol. 46 (1-2) , 177-196
- https://doi.org/10.1016/0378-3782(96)01763-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mass screening and occurrence of neuroblastoma in Sapporo CityScreening, 1993
- Comparison of HPLC and ELISA methods in neuroblastoma screeningScreening, 1993
- Neuroblastoma: A 32‐year population‐based study—implications for screeningMedical and Pediatric Oncology, 1993
- A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVAJournal of Pediatric Surgery, 1989
- Feasibility study for neonatal neuroblastoma screening in the United StatesMedical and Pediatric Oncology, 1989
- Thin‐layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large‐scale neuroblastoma mass screeningMedical and Pediatric Oncology, 1989
- Biochemical screening for neuroblastoma in infants: A feasibility studyMedical and Pediatric Oncology, 1989
- Newborn urine screening experience with over one million infants in the Quebec Network of Genetic MedicineJournal of Inherited Metabolic Disease, 1987
- Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.The Tohoku Journal of Experimental Medicine, 1986
- Neuroblastoma. Mass screening for early detection and its prognosisCancer, 1984